v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from Operating Activities    
Net loss $ (12,076,028) $ (12,813,325)
Adjustment to reconcile net loss to net cash used in operating activities:    
Changes in fair value of warrant liabilities (715,250) (7,496,500)
Changes in fair value of earn-out liabilities (519,000) (460,000)
Share-based compensation 2,599,171 3,552,984
Amortization of step-up in loans held for investment 0 169,607
Provision for credit losses on loans held for investment 638,450 1,152,420
Origination of loans and leases for resale (25,570,378) (14,825,985)
Proceeds from sale of loans and leases for resale 29,747,924 16,384,107
Gain on sale of loans and leases (4,177,546) (1,558,122)
Recovery of lease merchandise (69,327) 0
Loss on disposal of furniture 8,559 0
Depreciation and amortization 3,564,253 2,893,612
Non-cash operating lease expense 158,141 114,410
Changes in operating assets and liabilities:    
Accounts receivable 25,987 (175,697)
Lease receivable 99,541 (152,463)
Interest receivable (20,268) 95,625
Inventory 605,832 122,135
Prepaid expenses and other current assets 337,905 223,867
Deposits 28,243 (21,705)
Accounts payable (456,908) (627,932)
Accrued expenses 201,346 249,917
Deferred revenue (726,419) 2,000,177
Operating lease liabilities (156,501) (112,688)
Net cash used in operating activities (6,472,273) (11,285,556)
Cash flows from Investing Activities    
Disposals/(Additions) to lease merchandise, net of disposals 420,161 (2,194,358)
Software development costs (1,184,571) (1,554,442)
Principal paydowns on loans held for investment 13,071,785 8,911,312
Disbursements for loans held for investment (15,019,888) (9,406,157)
Purchase of licenses 0 (455,000)
Net cash used in investing activities (2,712,513) (4,698,645)
Cash flows from Financing Activities    
Proceeds from revolving line of credit 7,916,764 4,761,935
Repayments on revolving line of credit (6,743,259) (4,532,580)
Net disbursement for closing costs from private equity transaction (22,091) 0
Proceeds from issuance of common stock at-the-market offering 248,733 361,528
Cash paid for stock issuance costs 0 (312,059)
Net cash provided by financing activities 1,400,147 278,824
Net decrease in cash, cash equivalents and restricted cash (7,784,639) (15,705,377)
Cash, cash equivalents and restricted cash, beginning of period 16,117,319 36,589,607
Cash, cash equivalents and restricted cash, end of the period 8,332,680 20,884,230
Cash and cash equivalents from continued operations 6,735,250 18,479,548
Restricted cash from continued operations 1,552,921 307,114
Cash and cash equivalents from discontinued operations 44,509 2,097,568
Total cash, cash equivalents and restricted cash, end of the period 8,332,680 20,884,230
Supplemental Cash Flow Information    
Cash paid for interest for convertible notes and revolving line of credit 947,469 868,457
Issuance of common shares in connection with the asset acquisition 0 4,500,000
Earnout liability generated by asset acquisition 0 550,000
Operating lease right-of-use asset obtained in exchange for operating lease liability 0 652,410
Accrued variable compensation settled with RSU grants $ 0 $ 597,397